当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3422
Allergan, Inc.
2011/10/31 0:00:00
MEMANTINE
DRUG FOR FURTHER PROCESSING
21
0456-3422_
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3429
Allergan, Inc.
2011/10/31 0:00:00
MEMANTINE
DRUG FOR FURTHER PROCESSING
28
0456-3429_
citalopram hydrobromide
DRUG FOR FURTHER PROCESSING
0456-4011
Allergan, Inc.
1998/7/17 0:00:00
CITALOPRAM
DRUG FOR FURTHER PROCESSING
10
0456-4011_
citalopram hydrobromide
DRUG FOR FURTHER PROCESSING
0456-4021
Allergan, Inc.
1998/7/17 0:00:00
CITALOPRAM
DRUG FOR FURTHER PROCESSING
20
0456-4021_
citalopram hydrobromide
DRUG FOR FURTHER PROCESSING
0456-4041
Allergan, Inc.
1998/7/17 0:00:00
CITALOPRAM
DRUG FOR FURTHER PROCESSING
40
0456-4041_
isavuconazonium sulfate
BULK INGREDIENT
0469-1020
Astellas Pharma US, Inc.
2015/3/6 0:00:00
ISAVUCONAZ
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
0.54
0469-1020_
mirabegron
BULK INGREDIENT
0469-2603
Astellas Pharma US, Inc.
2012/6/28 0:00:00
MIRABEGRON
BULK INGREDIENT
1
0469-2603_
Sumatriptan
DRUG FOR FURTHER PROCESSING
0480-2013
Teva Pharmaceutical Industries Ltd.
2016/4/1 0:00:00
SUMATRIPTA
DRUG FOR FURTHER PROCESSING
4
0480-2013_
Sumatriptan
DRUG FOR FURTHER PROCESSING
0480-2014
Teva Pharmaceutical Industries Ltd.
2016/4/1 0:00:00
SUMATRIPTA
DRUG FOR FURTHER PROCESSING
6
0480-2014_
Fexofenadine Hydrochloride
DRUG FOR FURTHER PROCESSING
0480-7252
Teva Pharmaceuticals, Inc.
2005/9/1 0:00:00
FEXOFENADI
DRUG FOR FURTHER PROCESSING
60
0480-7252_
Fexofenadine Hydrochloride
DRUG FOR FURTHER PROCESSING
0480-7253
Teva Pharmaceuticals, Inc.
2005/9/1 0:00:00
FEXOFENADI
DRUG FOR FURTHER PROCESSING
180
0480-7253_
Leucovorin Calcium
DRUG FOR FURTHER PROCESSING
0555-0484
Teva Pharmaceuticals USA, Inc.
2021/6/10 0:00:00
LEUCOVORIN
DRUG FOR FURTHER PROCESSING
5
0555-0484_
Leucovorin Calcium
DRUG FOR FURTHER PROCESSING
0555-0485
Teva Pharmaceuticals USA, Inc.
2021/6/10 0:00:00
LEUCOVORIN
DRUG FOR FURTHER PROCESSING
25
0555-0485_
esomeprazole magnesium
DRUG FOR FURTHER PROCESSING
0573-2453
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
2018/1/26 0:00:00
ESOMEPRAZO
DRUG FOR FURTHER PROCESSING
20
0573-2453_
hydrocortisone
BULK INGREDIENT
0574-0420
Padagis US LLC
1983/4/8 0:00:00
HYDROCORTI
DRUG FOR FURTHER PROCESSING
1
0574-0420_
HYDROCORTISONE ACETATE
BULK INGREDIENT
0574-0421
Padagis US LLC
1983/4/30 0:00:00
HYDROCORTI
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
1
0574-0421_
Lorazepam
DRUG FOR FURTHER PROCESSING
0591-0240
Actavis Pharma, Inc.
1991/10/31 0:00:00
LORAZEPAM
DRUG FOR FURTHER PROCESSING
0.5
0591-0240_
Lorazepam
DRUG FOR FURTHER PROCESSING
0591-0241
Actavis Pharma, Inc.
1991/10/31 0:00:00
LORAZEPAM
DRUG FOR FURTHER PROCESSING
1
0591-0241_
Lorazepam
DRUG FOR FURTHER PROCESSING
0591-0242
Actavis Pharma, Inc.
1991/10/31 0:00:00
LORAZEPAM
DRUG FOR FURTHER PROCESSING
2
0591-0242_
Verapamil Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0343
Actavis Pharma, Inc.
1986/10/1 0:00:00
VERAPAMIL
DRUG FOR FURTHER PROCESSING
80
0591-0343_
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3